Our Lady of the Lake Cancer Institute Awarded Designation as Center of Excellence in Lung Cancer Care

December 12, 2024

Baton Rouge, LA — Our Lady of the Lake Cancer Institute has been named a Center of Excellence (COE) by GO2 for Lung Cancer (GO2) for its ongoing commitment to providing the Baton Rouge community with patient-centered, evidence-based lung cancer care. An estimated 237,000 Americans are diagnosed with lung cancer annually, and while it remains the leading cause of cancer deaths, lung cancer survival rates are growing at a rapid pace thanks to the availability of new, groundbreaking treatments for people diagnosed with the disease.

“Our Lady of the Lake Cancer Institute is dedicated to providing patients with the highest quality care,” said Susan Foret, vice president of operations at Our Lady of the Lake Cancer Institute. “We are thrilled to be part of this elite network, setting an example for responsible treatment and care practices across the country and helping people diagnosed with lung cancer in our community live longer, higher-quality lives.”

GO2 COEs designated in lung cancer care are committed to the principles of patient-centered communication and decision making across the entire care pathway. They demonstrate access to standard cancer services within medical, radiation, and surgical oncology, and pathology; follow practice standards based on evidence, expert consensus, and clinical guidelines; and engage team-based mechanisms for multidisciplinary input to guide care and treatment recommendations and inform shared decision making.

“We are proud to have Our Lady of the Lake Cancer Institute join the community of GO2 for Lung Cancer Centers of Excellence that is national in scope and local in impact,” said GO2 Chief Healthcare Delivery Officer, Joelle Fathi. “Across the U.S., the majority of people at risk for or living with lung cancer are served by a local community hospital near their home. Through the GO2 COE network of community hospitals, clinics, and academic and VA medical centers, we are fostering and supporting essential knowledge sharing and collaboration that brings national and global advancements in early detection, treatment and care close to home.”

In addition to receiving this newly awarded designation as a Center of Excellence in Lung Cancer Care, Our Lady of the Lake Cancer Insitute is also recognized by GO2 as a Center of Excellence in:

• Lung Cancer Screening, for implementing a structured low-dose CT screening program that adheres to NCCN, USPSTF, or CMS criteria and uses a standardized process to manage patient follow-through.
• Incidental Pulmonary Nodules, for providing a structured program that captures incidentally found lung nodules from imaging, with a standardized process for patient follow-up and reporting across the health system.
• Biomarker Testing and Precision Medicine, for ensuring access to guideline-directed testing for molecular and immune biomarkers with next generation sequencing technology in all patients with guideline-eligible tumors to determine eligibility for targeted therapies or immunotherapies.
• Smoking Cessation, for consistently supplying evidence-based smoking cessation services and information across the lung cancer continuum.
• Multidisciplinary Team, for providing a patient-centric multidisciplinary team comprised of a cancer navigator or coordinator and a minimum of three lung cancer disciplines that meet at a regularly scheduled tumor board.
• Survivorship, for facilitating survivorship care plans and resources to improve quality of life among all people with lung cancer.
• Patient Centric Research, for consistently navigating people with lung cancer to clinical trial opportunities when appropriate.
• Community Engagement, for participating in community outreach to expand lung cancer awareness and education.
• Equity, for demonstrating an approach to lung cancer care that considers diversity, health equity and inclusion for all community members.